Literature DB >> 7116071

A comparison of depression rating scales.

N P Kearns, C A Cruickshank, K J McGuigan, S A Riley, S P Shaw, R P Snaith.   

Abstract

In a comparison of assessment methods of severity of depressive illness, the Montgomery-Asberg Scale had, broadly, a performance equal to the Hamilton Scale. The Beck Depression Inventory, it subscale, and the Wakefield Inventory all had overall poor performances and should now be abandoned in research. The two-patient-rated scales were, overall, similar and fairly satisfactory measures. The comparisons were at points in severity of illness and not on change of severity.

Entities:  

Mesh:

Year:  1982        PMID: 7116071     DOI: 10.1192/bjp.141.1.45

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  44 in total

Review 1.  A review of health-related quality-of-life measures in stroke.

Authors:  B A Golomb; B G Vickrey; R D Hays
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

Review 3.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

4.  Psychopathology and functioning among children of treated depressed fathers and mothers.

Authors:  Daniel J Pilowsky; Priya Wickramaratne; Ernest Poh; Mariely Hernandez; Lisa A Batten; Martine F Flament; Jonathan W Stewart; Pierre Blier; Myrna M Weissman
Journal:  J Affect Disord       Date:  2014-04-18       Impact factor: 4.839

5.  A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children.

Authors:  Shailesh Jain; Thomas J Carmody; Madhukar H Trivedi; Carroll Hughes; Ira H Bernstein; David W Morris; Graham J Emslie; A John Rush
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-09       Impact factor: 8.829

6.  Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.

Authors:  P Bech; P Allerup; N Reisby; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Screening for depressive symptoms in patients with unresectable lung cancer.

Authors:  S Néron; J A Correa; E Dajczman; G Kasymjanova; H Kreisman; D Small
Journal:  Support Care Cancer       Date:  2007-02-14       Impact factor: 3.603

8.  Effectiveness of adjuvant occupational therapy in employees with depression: design of a randomized controlled trial.

Authors:  Hiske L Hees; Maarten W J Koeter; Gabe de Vries; Wendy Ooteman; Aart H Schene
Journal:  BMC Public Health       Date:  2010-09-17       Impact factor: 3.295

9.  Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.

Authors:  Matthew P Ward; Pedro P Irazoqui
Journal:  Front Neuroeng       Date:  2010-05-31

10.  Depression in lung cancer patients: is the HADS an effective screening tool?

Authors:  Lorys Castelli; Luca Binaschi; Paola Caldera; Riccardo Torta
Journal:  Support Care Cancer       Date:  2009-03-13       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.